The stock is in a volatile uptrend over the past year, with a 1-year price change of +82.03%, but has experienced a sharp pullback from its 52-week high of $43.98. As of July 2, 2026, the stock closed at $19.15, which is only 43.5% of its 52-week range (from low of $9.32 to high of $43.98), indicating it is trading near the lower end of its range after a significant correction. This positioning suggests the stock may be oversold or facing a loss of momentum, but could also represent a value entry if the long-term thesis holds. The 1-month price change is -37.62%, while the 3-month change is +20.29%, showing a sharp deceleration in short-term momentum. The 1-month decline contrasts sharply with the 1-year uptrend, signaling a potential trend reversal or a severe pullback within a broader uptrend. The relative strength versus the S&P 500 is -36.37% over 1 month, indicating significant underperformance. The stock's beta of 2.481 implies it is nearly 2.5 times more volatile than the market, amplifying both gains and losses. The 52-week low of $9.32 provides a support level, while the 52-week high of $43.98 is a resistance. A break below $9.32 would signal a breakdown, while a move above $43.98 would indicate a resumption of the uptrend. The high beta suggests that position sizing should be conservative to manage risk.

Revenue is highly erratic, with Q4 2025 reporting only $1.643 million, a sharp drop from Q3 2025's $312.489 million, which itself was a spike from zero revenue in prior quarters. The YoY growth rate is not meaningful due to the lumpy revenue pattern, but the Q3 2025 revenue surge was driven by a large contract or acquisition-related revenue. The company is not yet generating consistent recurring revenue, and the investment case hinges on future production from its magnet plant. Net income was -$50.205 million in Q4 2025, following a -$156.68 million loss in Q3 2025, though Q1 2025 had a positive net income of $51.832 million due to a one-time gain. Gross margin was 11.87% in Q4 2025, down from 81.48% in Q3 2025, indicating low profitability on core operations. The company is deeply unprofitable on an operating basis, with operating margin of -15.90% in Q4 2025. The balance sheet shows a current ratio of 10.17 and a debt-to-equity ratio of only 0.0062, indicating strong liquidity and minimal leverage. However, free cash flow was negative $27.898 million in Q4 2025, though trailing twelve-month free cash flow was positive $114.228 million, largely due to capital raises. ROE is -60.40%, reflecting significant shareholder dilution and losses. The company relies on external financing (equity and government funding) to fund operations, as evidenced by $256.382 million in net cash from financing in Q4 2025.